X4 Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat cancer and rare disease, today announced that Paula Ragan, PhD, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference in Boston on Wednesday, March 8, 2017, at 9:00 a.m. ET.

This entry was posted in Recent Development News: Q1 - 2017, Recent Developments. Bookmark the permalink.
Read Full Article »